Surveillance Epidemiology and End Results (SEER)

The National Institutes of Health (NIH) established this Master IDIQ on April 27, 2018 to procure population-based cancer registry services supporting the Surveillance Epidemiology and End Results (SEER) Program, with ordering authority extending through April 30, 2028. The vehicle carries a combined ceiling of $500 million and no set-aside restrictions.

Ordering activity remains open with approximately 21 months of ordering authority remaining. The vehicle has obligated $383.6 million against $483.4 million in combined potential value across 63 task orders, representing 79% utilization. Award momentum has declined notably: the portfolio averaged 19 orders annually in 2019 but dropped to 2 orders in 2024, with the most recent award issued September 17, 2024.

Task orders fund cancer incidence, treatment, and survival data collection at population-based registries nationwide. Core infrastructure orders dominate the portfolio and typically extend through April 30, 2028 using cost-sharing or cost-no-fee pricing; these include large multi-year awards such as delivery order 75N91018D00004-75N91018F00001 ($47.8 million ceiling), 75N91018D00032-75N91018F00001 ($49.1 million ceiling), and 75N91018D00012-75N91018F00001 ($45.9 million ceiling). Ancillary programs include patterns-of-care studies, virtual tissue repository pilots, pediatric whole slide imaging projects, and SEER*EDUCATE educational initiatives. Typical task orders under $200,000 execute in one to two years; core infrastructure awards run substantially larger and multi-year.

All 63 task orders are unrestricted (no set-aside). The National Cancer Institute is the sole customer, serving 100% of orders.

Competition is concentrated among university and public health institutions. The University of California, San Francisco (UCSF) leads by potential value with $49.5 million across three orders; Fred Hutchinson Cancer Center and The University of Iowa hold $52.2 million and $46.3 million respectively. These top five primes by value (including Public Health Institute and University of Southern California) represent 49% of combined potential value. Louisiana State University Health Sciences Center, University of Kentucky, University of Hawaii, and University of Utah rank highest by order count but collectively represent a smaller share of dollars. Place of performance varies by registry jurisdiction across the United States; administrative oversight sits at NIH.

The purpose of this acquisition is to obtain the services of population-based central cancer registries to collect and report on population-based cancer incidence, treatment, and survival data. The Surveillance Epidemiology and End Results (SEER) Program is the NCI's major resource for measuring changes in incidence, morbidity, and mortality associated with cancer.